# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-25-096760
Filing Date
2025-07-18
Accepted
2025-07-18 08:00:16
Documents
18
Period of Report
2025-07-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | itrm-20250718.htm iXBRL | PRE 14A | 1948616
2 | GRAPHIC | img249205814_0.jpg | GRAPHIC | 21045
3 | GRAPHIC | img249205814_1.jpg | GRAPHIC | 317341
4 | GRAPHIC | img249205814_2.jpg | GRAPHIC | 342984
5 | GRAPHIC | img249205814_3.jpg | GRAPHIC | 579155
6 | GRAPHIC | img249205814_4.jpg | GRAPHIC | 436150
| Complete submission text file | 0000950170-25-096760.txt |  | 6912952

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | itrm-20250718.xsd | EX-101.SCH | 14617
20 | EXTRACTED XBRL INSTANCE DOCUMENT | itrm-20250718_htm.xml | XML | 266745

Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38503 | Film No.: 251132634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)